Tonix Pharmaceuticals Prices Public Offering of 1,800,000 Shares of Common Stock

NEW YORK, March 30, 2017, TNXP, (GLOBE NEWSWIRE) Tonix Pharmaceuticals Holding Corp. (“Tonix”) (Nasdaq:TNXP), a company that is developing innovative pharmaceutical products to address public health challenges, announced today the pricing of an underwritten public offering of 1,800,000 shares of its common stock at a public offering price of $4.45 per share. The gross proceeds to Tonix from this offering are expected to be $8,010,000 before deducting underwriting discounts and commissions and other estimated offering expenses payable by Tonix. Tonix
http://bit.ly/2nARV6x